Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status-Reference-Cited by-同舟云学术

Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status

Published:2022-01-07 Issue:2 Volume:42 Page:419-424
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Aspite Silvia¹,Schepis Filippo²^ORCID,Roccarina Davide¹^ORCID,Gitto Stefano¹,Citone Michele³,Di Bonaventura Chiara¹,Bianchini Marcello²,Arena Umberto¹,Vannucchi Alessandro M.¹⁴⁵,Guglielmelli Paola¹⁴⁵,Campani Francesca⁶,Fanelli Fabrizio³,Marra Fabio¹⁵^ORCID,Vizzutti Francesco¹^ORCID

Affiliation:

1. Department of Experimental and Clinical Medicine University of Florence Florence Italy

2. Division of Gastroenterology Modena Hospital University of Modena and Reggio Emilia Modena Italy

3. Department of Radiology Interventional Radiology Unit Careggi Hospital Florence Italy

4. Center Research Innovation of Myeloproliferative Neoplasms (CRIMM) SOD Hematology University of Florence Florence Italy

5. Center for Research High Education and Transfer DENOThe University of Florence Florence Italy

6. Department of Health Science Careggi University Hospital

Funder

Università degli Studi di Firenze

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15148

Reference20 articles.

1. Myeloproliferative disorders: complications, survival and causes of death

2. THE NATURAL HISTORY OF AGNOGENIC MYELOID METAPLASIA (AMM) AND A CRITICAL EVALUATION OF ITS RELATIONSHIP WITH THE MYELOPROLIFERATIVE SYNDROME

3. Agnogenic Myeloid Metaplasia, Portal Hypertension, and Sinusoidal Abnormalities

4. Gastrointestinal and Abdominal Manifestations of Agnogenic Myeloid Metaplasia

5. Consensus conference on TIPS management: Techniques, indications, contraindications

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Portosystemic Shunt and Portal Vein Stent in Managing Portal Hypertension Due to Hematological Diseases;Cureus;2024-02-14

2. Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis—Pathogenesis, Implications and Therapeutic Opportunities;Nutrients;2023-12-21

3. Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study;Cancers;2023-09-24

4. Correlation between hepatic venous pressure gradient and portal pressure gradient in patients with autoimmune cirrhotic portal hypertension and collateral branches of the hepatic vein;Hepatology Research;2023-07-08

5. Treatment of Hypertension by Using Natural Herbs and their Mechanism of Action;Journal Of Biochemical Technology;2022